News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Taiho Pharmaceutical Licensed To Develop And Sell ABRAXANE Anti-Cancer Agent By American BioScience, Inc.


11/21/2005 1:03:19 PM

Tokyo (JCN) Nov 21, 2005- Taiho Pharmaceutical announced on November 16 that it has signed a licensing agreement with American BioScience for ABRAXANE, an anti-cancer agent. Under the agreement terms, Taiho will develop and sell the agent in Japan.

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES